Princeton Global Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $492K | Sell |
3,825
-627
| -14% | -$73.4K | 0.07% | 146 |
|
|
2026
Q1 | $536K | Buy |
4,452
+6
| +0.1% | +$693 | 0.09% | 125 |
|
|
2025
Q4 | $468K | Buy |
4,446
+1,440
| +48% | +$135K | 0.08% | 138 |
|
|
2025
Q3 | $252K | Sell |
3,006
-390
| -11% | -$32.1K | 0.04% | 177 |
|
|
2025
Q2 | $269K | Sell |
3,396
-5,998
| -64% | -$477K | 0.05% | 170 |
|
|
2025
Q1 | $843K | Sell |
9,394
-4,093
| -30% | -$382K | 0.17% | 105 |
|
|
2024
Q4 | $1.34M | Sell |
13,487
-11,095
| -45% | -$1.14M | 0.25% | 82 |
|
|
2024
Q3 | $2.79M | Buy |
24,582
+827
| +3% | +$98.3K | 0.54% | 55 |
|
|
2024
Q2 | $2.94M | Buy |
23,755
+7,015
| +42% | +$904K | 0.65% | 51 |
|
|
2024
Q1 | $2.21M | Sell |
16,740
-469
| -3% | -$57.8K | 0.53% | 58 |
|
|
2023
Q4 | $1.88M | Sell |
17,209
-856
| -5% | -$88.9K | 0.47% | 60 |
|
|
2023
Q3 | $1.86M | Sell |
18,065
-1,090
| -6% | -$117K | 0.53% | 60 |
|
|
2023
Q2 | $2.21M | Sell |
19,155
-16,040
| -46% | -$1.82M | 0.65% | 51 |
|
|
2023
Q1 | $3.74M | Buy |
35,195
+266
| +0.8% | +$28.7K | 1.08% | 26 |
|
|
2022
Q4 | $3.88M | Sell |
34,929
-370
| -1% | -$37.8K | 1.25% | 22 |
|
|
2022
Q3 | $3.04M | Sell |
35,299
-650
| -2% | -$58K | 1.06% | 29 |
|
|
2022
Q2 | $3.28M | Sell |
35,949
-300
| -0.8% | -$26.6K | 1.06% | 29 |
|
|
2022
Q1 | $2.97M | Sell |
36,249
-148
| -0.4% | -$11.7K | 0.83% | 36 |
|
|
2021
Q4 | $2.79M | Sell |
36,397
-176
| -0.5% | -$14K | 0.78% | 37 |
|
|
2021
Q3 | $2.75M | Sell |
36,573
-183
| -0.5% | -$13.9K | 0.84% | 38 |
|
|
2021
Q2 | $2.86M | Sell |
36,756
-817
| -2% | -$60.8K | 0.87% | 37 |
|
|
2021
Q1 | $2.76M | Sell |
37,573
-22
| -0.1% | -$1.62K | 0.89% | 34 |
|
|
2020
Q4 | $2.93M | Buy |
37,595
+8,579
| +30% | +$656K | 1.03% | 28 |
|
|
2020
Q3 | $2.3M | Sell |
29,016
-1,519
| -5% | -$119K | 0.93% | 34 |
|
|
2020
Q2 | $2.25M | Buy |
30,535
+27,353
| +860% | +$2.06M | 0.7% | 44 |
|
|
2020
Q1 | $234K | Buy |
3,182
+63
| +2% | +$4.95K | 0.1% | 145 |
|
|
2019
Q4 | $271 | Buy |
3,119
+1,519
| +95% | +$125K | 0.11% | 143 |
|
|
2019
Q3 | $128K | Sell |
1,600
-69
| -4% | -$5.53K | 0.07% | 160 |
|
|
2019
Q2 | $134K | Sell |
1,669
-476
| -22% | -$36.4K | 0.08% | 158 |
|
|
2019
Q1 | $170K | Buy |
2,145
+629
| +41% | +$47K | 0.12% | 141 |
|
|
2018
Q4 | $111K | Buy |
+1,516
| New | +$107K | 0.1% | 135 |
|
Other funds holding MRK
Princeton Global Asset Management's MRK Position: Q2 2026 in Review
Princeton Global Asset Management reduced its Merck (MRK) stake by 14% in Q2 2026, selling an estimated $73.4K and leaving 3,825 shares worth $492K. The position accounts for 0.07% of the portfolio, ranked #146.
Princeton Global Asset Management first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.88M in Q4 2022. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Princeton Global Asset Management held 3,825 shares of Merck worth $492K as of Q2 2026.
- Princeton Global Asset Management sold 627 Merck shares in Q2 2026, an estimated $73.4K.
- Merck made up 0.07% of Princeton Global Asset Management's portfolio in Q2 2026, its #146 holding.
- Princeton Global Asset Management first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Princeton Global Asset Management's Merck position peaked at $3.88M in Q4 2022.
- 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.